Cancer Testing/Screening Market
1 Introduction to Research & Analysis Reports
1.1 Cancer Testing/Screening Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Testing/Screening Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Testing/Screening Overall Market Size
2.1 Global Cancer Testing/Screening Market Size: 2021 VS 2028
2.2 Global Cancer Testing/Screening Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Testing/Screening Players in Global Market
3.2 Top Global Cancer Testing/Screening Companies Ranked by Revenue
3.3 Global Cancer Testing/Screening Revenue by Companies
3.4 Top 3 and Top 5 Cancer Testing/Screening Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cancer Testing/Screening Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Testing/Screening Players in Global Market
3.6.1 List of Global Tier 1 Cancer Testing/Screening Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Testing/Screening Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Cancer Testing/Screening Market Size Markets, 2021 & 2028
4.1.2 Magnetic Resonance Imaging (MRI)
4.1.3 Human Papillomavirus (HPV) Testing
4.1.4 Colonoscopy
4.1.5 Others
4.2 By Type - Global Cancer Testing/Screening Revenue & Forecasts
4.2.1 By Type - Global Cancer Testing/Screening Revenue, 2017-2022
4.2.2 By Type - Global Cancer Testing/Screening Revenue, 2023-2028
4.2.3 By Type - Global Cancer Testing/Screening Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Testing/Screening Market Size, 2021 & 2028
5.1.2 Lung Cancer
5.1.3 Blood Cancer
5.1.4 Bone Cancer
5.1.5 Gall Bladder Cancer
5.1.6 Others
5.2 By Application - Global Cancer Testing/Screening Revenue & Forecasts
5.2.1 By Application - Global Cancer Testing/Screening Revenue, 2017-2022
5.2.2 By Application - Global Cancer Testing/Screening Revenue, 2023-2028
5.2.3 By Application - Global Cancer Testing/Screening Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Cancer Testing/Screening Market Size, 2021 & 2028
6.2 By Region - Global Cancer Testing/Screening Revenue & Forecasts
6.2.1 By Region - Global Cancer Testing/Screening Revenue, 2017-2022
6.2.2 By Region - Global Cancer Testing/Screening Revenue, 2023-2028
6.2.3 By Region - Global Cancer Testing/Screening Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Cancer Testing/Screening Revenue, 2017-2028
6.3.2 US Cancer Testing/Screening Market Size, 2017-2028
6.3.3 Canada Cancer Testing/Screening Market Size, 2017-2028
6.3.4 Mexico Cancer Testing/Screening Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Cancer Testing/Screening Revenue, 2017-2028
6.4.2 Germany Cancer Testing/Screening Market Size, 2017-2028
6.4.3 France Cancer Testing/Screening Market Size, 2017-2028
6.4.4 U.K. Cancer Testing/Screening Market Size, 2017-2028
6.4.5 Italy Cancer Testing/Screening Market Size, 2017-2028
6.4.6 Russia Cancer Testing/Screening Market Size, 2017-2028
6.4.7 Nordic Countries Cancer Testing/Screening Market Size, 2017-2028
6.4.8 Benelux Cancer Testing/Screening Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Cancer Testing/Screening Revenue, 2017-2028
6.5.2 China Cancer Testing/Screening Market Size, 2017-2028
6.5.3 Japan Cancer Testing/Screening Market Size, 2017-2028
6.5.4 South Korea Cancer Testing/Screening Market Size, 2017-2028
6.5.5 Southeast Asia Cancer Testing/Screening Market Size, 2017-2028
6.5.6 India Cancer Testing/Screening Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Cancer Testing/Screening Revenue, 2017-2028
6.6.2 Brazil Cancer Testing/Screening Market Size, 2017-2028
6.6.3 Argentina Cancer Testing/Screening Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Testing/Screening Revenue, 2017-2028
6.7.2 Turkey Cancer Testing/Screening Market Size, 2017-2028
6.7.3 Israel Cancer Testing/Screening Market Size, 2017-2028
6.7.4 Saudi Arabia Cancer Testing/Screening Market Size, 2017-2028
6.7.5 UAE Cancer Testing/Screening Market Size, 2017-2028
7 Players Profiles
7.1 Dias Orin
7.1.1 Dias Orin Corporate Summary
7.1.2 Dias Orin Business Overview
7.1.3 Dias Orin Cancer Testing/Screening Major Product Offerings
7.1.4 Dias Orin Cancer Testing/Screening Revenue in Global Market (2017-2022)
7.1.5 Dias Orin Key News
7.2 Epigenetics
7.2.1 Epigenetics Corporate Summary
7.2.2 Epigenetics Business Overview
7.2.3 Epigenetics Cancer Testing/Screening Major Product Offerings
7.2.4 Epigenetics Cancer Testing/Screening Revenue in Global Market (2017-2022)
7.2.5 Epigenetics Key News
7.3 Techlab
7.3.1 Techlab Corporate Summary
7.3.2 Techlab Business Overview
7.3.3 Techlab Cancer Testing/Screening Major Product Offerings
7.3.4 Techlab Cancer Testing/Screening Revenue in Global Market (2017-2022)
7.3.5 Techlab Key News
7.4 Positive Bioscience
7.4.1 Positive Bioscience Corporate Summary
7.4.2 Positive Bioscience Business Overview
7.4.3 Positive Bioscience Cancer Testing/Screening Major Product Offerings
7.4.4 Positive Bioscience Cancer Testing/Screening Revenue in Global Market (2017-2022)
7.4.5 Positive Bioscience Key News
7.5 Genextropy
7.5.1 Genextropy Corporate Summary
7.5.2 Genextropy Business Overview
7.5.3 Genextropy Cancer Testing/Screening Major Product Offerings
7.5.4 Genextropy Cancer Testing/Screening Revenue in Global Market (2017-2022)
7.5.5 Genextropy Key News
7.6 M Genomics
7.6.1 M Genomics Corporate Summary
7.6.2 M Genomics Business Overview
7.6.3 M Genomics Cancer Testing/Screening Major Product Offerings
7.6.4 M Genomics Cancer Testing/Screening Revenue in Global Market (2017-2022)
7.6.5 M Genomics Key News
7.7 20/20 GeneSystems
7.7.1 20/20 GeneSystems Corporate Summary
7.7.2 20/20 GeneSystems Business Overview
7.7.3 20/20 GeneSystems Cancer Testing/Screening Major Product Offerings
7.7.4 20/20 GeneSystems Cancer Testing/Screening Revenue in Global Market (2017-2022)
7.7.5 20/20 GeneSystems Key News
7.8 AB SCIEX
7.8.1 AB SCIEX Corporate Summary
7.8.2 AB SCIEX Business Overview
7.8.3 AB SCIEX Cancer Testing/Screening Major Product Offerings
7.8.4 AB SCIEX Cancer Testing/Screening Revenue in Global Market (2017-2022)
7.8.5 AB SCIEX Key News
7.9 Abbott Laboratories
7.9.1 Abbott Laboratories Corporate Summary
7.9.2 Abbott Laboratories Business Overview
7.9.3 Abbott Laboratories Cancer Testing/Screening Major Product Offerings
7.9.4 Abbott Laboratories Cancer Testing/Screening Revenue in Global Market (2017-2022)
7.9.5 Abbott Laboratories Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Cancer Testing/Screening Market Opportunities & Trends in Global Market
Table 2. Cancer Testing/Screening Market Drivers in Global Market
Table 3. Cancer Testing/Screening Market Restraints in Global Market
Table 4. Key Players of Cancer Testing/Screening in Global Market
Table 5. Top Cancer Testing/Screening Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cancer Testing/Screening Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cancer Testing/Screening Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cancer Testing/Screening Product Type
Table 9. List of Global Tier 1 Cancer Testing/Screening Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Testing/Screening Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Cancer Testing/Screening Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cancer Testing/Screening Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cancer Testing/Screening Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Cancer Testing/Screening Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cancer Testing/Screening Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cancer Testing/Screening Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Cancer Testing/Screening Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cancer Testing/Screening Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cancer Testing/Screening Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cancer Testing/Screening Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cancer Testing/Screening Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cancer Testing/Screening Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cancer Testing/Screening Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cancer Testing/Screening Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cancer Testing/Screening Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cancer Testing/Screening Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cancer Testing/Screening Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cancer Testing/Screening Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cancer Testing/Screening Revenue, (US$, Mn), 2023-2028
Table 30. Dias Orin Corporate Summary
Table 31. Dias Orin Cancer Testing/Screening Product Offerings
Table 32. Dias Orin Cancer Testing/Screening Revenue (US$, Mn), (2017-2022)
Table 33. Epigenetics Corporate Summary
Table 34. Epigenetics Cancer Testing/Screening Product Offerings
Table 35. Epigenetics Cancer Testing/Screening Revenue (US$, Mn), (2017-2022)
Table 36. Techlab Corporate Summary
Table 37. Techlab Cancer Testing/Screening Product Offerings
Table 38. Techlab Cancer Testing/Screening Revenue (US$, Mn), (2017-2022)
Table 39. Positive Bioscience Corporate Summary
Table 40. Positive Bioscience Cancer Testing/Screening Product Offerings
Table 41. Positive Bioscience Cancer Testing/Screening Revenue (US$, Mn), (2017-2022)
Table 42. Genextropy Corporate Summary
Table 43. Genextropy Cancer Testing/Screening Product Offerings
Table 44. Genextropy Cancer Testing/Screening Revenue (US$, Mn), (2017-2022)
Table 45. M Genomics Corporate Summary
Table 46. M Genomics Cancer Testing/Screening Product Offerings
Table 47. M Genomics Cancer Testing/Screening Revenue (US$, Mn), (2017-2022)
Table 48. 20/20 GeneSystems Corporate Summary
Table 49. 20/20 GeneSystems Cancer Testing/Screening Product Offerings
Table 50. 20/20 GeneSystems Cancer Testing/Screening Revenue (US$, Mn), (2017-2022)
Table 51. AB SCIEX Corporate Summary
Table 52. AB SCIEX Cancer Testing/Screening Product Offerings
Table 53. AB SCIEX Cancer Testing/Screening Revenue (US$, Mn), (2017-2022)
Table 54. Abbott Laboratories Corporate Summary
Table 55. Abbott Laboratories Cancer Testing/Screening Product Offerings
Table 56. Abbott Laboratories Cancer Testing/Screening Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Cancer Testing/Screening Segment by Type in 2021
Figure 2. Cancer Testing/Screening Segment by Application in 2021
Figure 3. Global Cancer Testing/Screening Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Cancer Testing/Screening Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cancer Testing/Screening Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Testing/Screening Revenue in 2021
Figure 8. By Type - Global Cancer Testing/Screening Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cancer Testing/Screening Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cancer Testing/Screening Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cancer Testing/Screening Revenue Market Share, 2017-2028
Figure 12. US Cancer Testing/Screening Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cancer Testing/Screening Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cancer Testing/Screening Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cancer Testing/Screening Revenue Market Share, 2017-2028
Figure 16. Germany Cancer Testing/Screening Revenue, (US$, Mn), 2017-2028
Figure 17. France Cancer Testing/Screening Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cancer Testing/Screening Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cancer Testing/Screening Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cancer Testing/Screening Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cancer Testing/Screening Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cancer Testing/Screening Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cancer Testing/Screening Revenue Market Share, 2017-2028
Figure 24. China Cancer Testing/Screening Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cancer Testing/Screening Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cancer Testing/Screening Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cancer Testing/Screening Revenue, (US$, Mn), 2017-2028
Figure 28. India Cancer Testing/Screening Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cancer Testing/Screening Revenue Market Share, 2017-2028
Figure 30. Brazil Cancer Testing/Screening Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cancer Testing/Screening Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cancer Testing/Screening Revenue Market Share, 2017-2028
Figure 33. Turkey Cancer Testing/Screening Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cancer Testing/Screening Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cancer Testing/Screening Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cancer Testing/Screening Revenue, (US$, Mn), 2017-2028
Figure 37. Dias Orin Cancer Testing/Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Epigenetics Cancer Testing/Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Techlab Cancer Testing/Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Positive Bioscience Cancer Testing/Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Genextropy Cancer Testing/Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. M Genomics Cancer Testing/Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. 20/20 GeneSystems Cancer Testing/Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AB SCIEX Cancer Testing/Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Abbott Laboratories Cancer Testing/Screening Revenue Year Over Year Growth (US$, Mn) & (2017-2022)